Xuejing Huang

Guangxi Key Laboratory Of Bioactive Molecules Research And Evaluation, 22 Shuangyong Road
Nanning, 530021, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Reengineering glycyrrhetinic acid into a therapeutic oligomer for targeted tumor therapy with cardioprotection.

Reengineering glycyrrhetinic acid into a therapeutic oligomer for targeted tumor therapy with cardioprotection.

Journal: Journal of nanobiotechnology
Published: July 10, 2025

Transcriptomics assisted by metabolomics analysis provides insights into regulation mechanisms during carcinogenic process in a hydrodynamically transfected liver cancer model.

Transcriptomics assisted by metabolomics analysis provides insights into regulation mechanisms during carcinogenic process in a hydrodynamically transfected liver cancer model.

Journal: Cancer cell international
Published: December 18, 2024

pir-hsa-216911 inhibit pyroptosis in hepatocellular carcinoma by suppressing TLR4 initiated GSDMD activation.

pir-hsa-216911 inhibit pyroptosis in hepatocellular carcinoma by suppressing TLR4 initiated GSDMD activation.

Journal: Cell death discovery
Published: October 06, 2024

2D-on-2D Al-Doped NiCo LDH Nanosheet Arrays for Fabricating High-Energy-Density, Wide Voltage Window, and Ultralong-Lifespan Supercapacitors.

2D-on-2D Al-Doped NiCo LDH Nanosheet Arrays for Fabricating High-Energy-Density, Wide Voltage Window, and Ultralong-Lifespan Supercapacitors.

Journal: Small (Weinheim an der Bergstrasse, Germany)
Published: February 19, 2024

Ethanol responsive lnc171 promotes migration and invasion of HCC cells via mir-873-5p/ZEB1 axis.

Ethanol responsive lnc171 promotes migration and invasion of HCC cells via mir-873-5p/ZEB1 axis.

Journal: BMC cancer
Published: December 26, 2023

Increased hsa-miR-100-5p Expression Improves Hepatocellular Carcinoma Prognosis in the Asian Population with PLK1 Variant rs27770A>G.

Increased hsa-miR-100-5p Expression Improves Hepatocellular Carcinoma Prognosis in the Asian Population with PLK1 Variant rs27770A>G.

Journal: Cancers
Published: September 26, 2023

Vasorin Deletion in C57BL/6J Mice Induces Hepatocyte Autophagy through Glycogen-Mediated mTOR Regulation.

Vasorin Deletion in C57BL/6J Mice Induces Hepatocyte Autophagy through Glycogen-Mediated mTOR Regulation.

Journal: Nutrients
Published: July 30, 2022

Vasorin contributes to lung injury via FABP4-mediated inflammation.

Vasorin contributes to lung injury via FABP4-mediated inflammation.

Journal: Molecular biology reports
Published: February 25, 2022

Optimised expression and purification of RBP4 and preparation of anti-RBP4 monoclonal antibody.

Optimised expression and purification of RBP4 and preparation of anti-RBP4 monoclonal antibody.

Journal: FEBS open bio
Published: July 14, 2021

Vasorin deficiency leads to cardiac hypertrophy by targeting MYL7 in young mice.

Vasorin deficiency leads to cardiac hypertrophy by targeting MYL7 in young mice.

Journal: Journal of cellular and molecular medicine
Published: May 05, 2021

Preparation of an anti-NEK2 monoclonal antibody and its application in liver cancer.

Preparation of an anti-NEK2 monoclonal antibody and its application in liver cancer.

Journal: BMC biotechnology
Published: March 15, 2021

Protein tyrosine phosphatase receptor type D (PTPRD)-mediated signaling pathways for the potential treatment of hepatocellular carcinoma: a narrative review.

Protein tyrosine phosphatase receptor type D (PTPRD)-mediated signaling pathways for the potential treatment of hepatocellular carcinoma: a narrative review.

Journal: Annals of translational medicine
Published: November 26, 2020
Showing 1-12 of 15

Last Updated: 09/26/2026